Jens-Peter Volkmer

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis

Yoko Kojima, Jens-Peter Volkmer, Kelly M. McKenna et al. · Nature · 2016 · 630 citations · Full text

Immunology, Autoimmunity, Immunotherapy +3

Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham et al. · Proceedings of the National Academy of Sciences · 2013 · 629 citations · Full text

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik et al. · Journal of Clinical Oncology · 2019 · 564 citations · Full text

Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies

Kipp Weiskopf, Aaron M. Ring, Chia Chi M. Ho et al. · Science · 2013 · 481 citations · Full text

Cancer Immunosurveillance, Cd47 Antagonist, Immunoengineering +14

Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk

Mingye Feng, James Y. Chen, Rachel Weissman-Tsukamoto et al. · Proceedings of the National Academy of Sciences · 2015 · 254 citations · Full text